Breaking News

You are here » Indian-Commodity  :  Corporate  :  Monnet Ispat and Energy's net loss widens to Rs 2,860 crore in Q2


Monnet Ispat and Energy's net loss widens to Rs 2,860 crore in Q2

Monnet Ispat and Energy has reported results for second quarter ended September 30, 2018.

The company has reported net loss of Rs 2,859.56 crore for the quarter under review as compared to the net loss of Rs crore 353.24 for the same quarter in the previous year. However, total income of the company increased by 32.87% at Rs 423.03 crore for Q2FY19 as compared Rs 318.39 crore for the corresponding quarter previous year.

Monnet Ispat and Energy is a holding company. The company is engaged in the business of conducting coal mining operations and manufacturing coal-based sponge iron and various other steel/iron-based products.

Related News

View all news

IndiGo launches new offer for domestic, international flights: Report

InterGlobe Aviation (IndiGo) has reportedly launched new offer at Rs 899 for domestic flights and Rs 3,199 for international flights in its new sale. The 'Fare-tastic Winters!' offer is starting from November......

HDFC Bank to hike stake in CCIL

HDFC Bank will acquire 4% equity stake in Clearing Corporation of India (CCIL). The Bank currently holds 5% of the total equity capital of CCIL. Hence, it is proposed to increase the stake in CCIL from......

Indiabulls Housing Finance raises Rs 23,615 crore in last 2 months

Indiabulls Housing Finance has raised Rs 23,615 crore in the last 2 months from 32 financial institutions in various debt instruments, securitization and sanctions. Of the total of Rs 23,615 crore raised,......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......